Lipopolysaccharides inhibit lymphosarcoma cells of bone marrow orgin.
D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004915:Leukemia, Erythroblastic, Acute; D007951:Leukemia, Myeloid; D008070:Lipopolysaccharides / Q000302:isolation & purification / Q000494:pharmacology*; D008223:Lymphoma; D008228:Lymphoma, Non-Hodgkin / Q000378:metabolism*; D012515:Mast-Cell Sarcoma; D051379:Mice; D008807:Mice, Inbred BALB C; D009101:Multiple Myeloma; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009374:Neoplasms, Experimental; D011135:Polysaccharides, Bacterial / Q000494:pharmacology*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D012485:Salmonella typhi / Q000032:analysis*; D013601:T-Lymphocytes / Q000187:drug effects; D014316:Tritium
D004273:DNA, Neoplasm; D008070:Lipopolysaccharides; D009363:Neoplasm Proteins; D011135:Polysaccharides, Bacterial; D012334:RNA, Neoplasm; D014316:Tritium